Navigation Links
EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
Date:5/15/2009

ENMD-2076 Clinical Program Adds Leukemia Clinical Study and Orphan Drug Designation

ROCKVILLE, Md., May 15 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer today announced presentations for three of its clinical-stage drug candidates at the American Society of Clinical Oncology (ASCO) Annual Meeting to be held May 29 - June 2, 2009 in Orlando, Florida. Presentations include both poster and discussion sessions and are listed below.

  • Poster Session: Friday, May 29, 2009 - 2:00 p.m. - 6:00 p.m. Abstract No.: 3520, "An open-label, dose escalation, safety, and pharmacokinetic study of ENMD-2076 administered orally to patients with advanced cancer."
    • Discussion Session: Friday, May 29, 2009 - 5:00 p.m. - 5:15 p.m. "Angiogenesis Inhibitors: New Agents and New Combinations," Level 4, Valencia Room, W415D.
  • Poster Session: Saturday, May 30, 2009 - 8:00 a.m. - 12:00 p.m. Abstract No.: 3562, "A single center, open-label, dose escalation, safety, and pharmacokinetic study of ENMD-1198 administered orally to patients with advanced cancer."
  • Poster Session: Sunday, May 31, 2009 - 2:00 p.m. - 6:00 p.m. Abstract No: 5577, "Phase 2 study of MKC-1 in patients with metastatic or resistant epithelial ovarian cancer or advanced endometrial cancer."

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

The Company has furth
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
2. EntreMed to Present at the New York Society of Security Analysts Industry Conference
3. EntreMeds MKC-1 Meets Primary Efficacy Endpoint in Non-Small Cell Lung Cancer Clinical Trial
4. EntreMed Reports Third Quarter 2008 Financial Results
5. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
6. EntreMed to Present at BioPartnering Europe Conference
7. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
8. EntreMed Reports Second Quarter 2008 Financial Results
9. EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
10. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
11. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2013)... This training is ideal for those who will ... software industry or those who want to explore Agile and ... The topics that will be covered in the 1-day Agile ... scrum artifacts, and scrum simulation (optional). , The trainings ... June 28, 2013 , Click here to register for a ...
(Date:6/14/2013)... June 14, 2013 These couplings are ... come equipped with a new and improved “Easy Grip ... more secure grip and reliable connection every time. , ... for use on medical applications such as ... pressure cuff manufacturers with better, more reliable, high quality, ...
(Date:6/14/2013)... Rosacea is said to affect 16 million Americans, eczema, ... it seems that most of the population have one or ... reports, often deciphering the difference between one skin condition ... have similar symptoms. Probiotic Action explains how these skin conditions ... effectively. , Rosacea, Acne and Eczema are conditions that react ...
(Date:6/14/2013)... , June 14, 2013  The Pittsburgh Life Sciences ... levels of investment that were necessitated by delays in ... investment climate and the uncertainty of state funding. ... said, "As the region,s only pure life sciences investment ... by the PLSG Board of Directors, were necessary to ...
Breaking Biology Technology:Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 3Rosacea, Acne, or Eczema? Probiotic Action Offers a Topical Probiotic to Treat the Most Common Skin Conditions 2Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding 2
... ... investment bank KTA Capital,s client Neuren Pharmaceuticals Ltd (ASX:NEU) has agreed an AU$6.7 mil ... by KTA Capital as Neuren,s exclusive placement agent and advisor. , ... New York (PRWEB) November 23, 2009 ...
... ... field remains the only one to show consistent growth during the U.S. recession. However, clinics ... actually cut medical personnel, instead of just administrators. , ... (Vocus) November 24, 2009 -- Health care employment continued growing in ...
... 24 Blue Marble Energy Corp. announced today that ... were recently awarded $2 million by Washington State,s Community ... construct the state,s first specialty biochemical biorefinery in Lincoln ... speed the development of our biorefinery and bring over ...
Cached Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
(Date:6/16/2013)... HIV prevention programs for female sex workers in India ... infections (STIs), a University of Toronto study has found. ... with HIV, mostly in the southern states of Andhra ... by Professor Prabhat Jha from U of T,s Dalla ... Centre for Global Health Research (CGHR), examined the impact ...
(Date:6/16/2013)... snap" 116 million years ago triggered a similar marine ... a result of global warming, according to research published ... involving experts from the universities of Newcastle, UK, Cologne, ... and a crash in the marine ecosystem during the ... the first time the amplitude and duration of the ...
(Date:6/14/2013)... Oklahoma researchers will collaborate with researchers from Oklahoma ... the University of Tulsa to advance understanding of ... climate change and variability in the state. , ... receive a $20 million National Science Foundation Experimental ... strategically aligned, innovative research over the next five ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2Global cooling as significant as global warming 2OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3
... An international team of scientists, including botanists from the University ... be used to catalogue the world,s plants using a technique ... method that uses a short genetic marker in an organism,s ... "Barcoding provides an efficient means by which we can ...
... promising data from a clinical study showing patient-specific ... and immune cells were well tolerated and resulted ... metastatic melanoma whose disease had been minimized by ... "Phase II Trial of Dendritic Cells Loaded with ...
... Mitochondrial diseases disrupt the power generating machinery within cells ... in the lungs or respiratory tract. A new study ... shows that infection with the pneumonia causing bacteria ... a signaling protein that is associated with mitochondrial disease. ...
Cached Biology News:University of Toronto helps to 'barcode' the world's plants 2Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma 2Stress signals link pre-existing sickness with susceptibility to bacterial infection 2
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
Biology Products: